Nalaganje...
Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?
Assessing progression of disease or response to treatment remains a major challenge in the clinical management of nontuberculous mycobacterial (NTM) infections of the lungs. Serial assessments of validated measures of treatment response address whether the current therapeutic approach is on track to...
Shranjeno v:
| izdano v: | Front Microbiol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6256187/ https://ncbi.nlm.nih.gov/pubmed/30524407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2018.02813 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|